|Bid||26.65 x 800|
|Ask||26.76 x 1000|
|Day's Range||26.06 - 27.72|
|52 Week Range||18.03 - 55.16|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 02, 2023 - Aug 07, 2023|
|Forward Dividend & Yield||8.00 (29.57%)|
|Ex-Dividend Date||May 19, 2023|
|1y Target Est||43.00|
Subscribe to Yahoo Finance Plus to view Fair Value for IEPLearn more
For much of his nearly half-century career on Wall Street, Carl Icahn has been known as an activist investor. Shares of Icahn Enterprises fell by 55.6% in May, according to data provided by S&P Global Market Intelligence, in the wake of that report and other commentary that followed. Icahn is one of the best-known activist investors, with a strong track record dating back to the early 1980s of agitating corporate boards to make changes that he feels will boost share prices.
Ackman and Icahn are both legendary investors, and the two have butted heads on several occasions, dating back to the early 2000s.
The billionaire who built his entire career as a nightmare for corporate CEOs is a victim of what made him successful.
Is your portfolio waving a red flag? Do you have some stocks that are in peril? Those are what we call red flag stocks. Historically, red flags were used as a visual signal to indicate a warning or danger ahead. Red flags signal dangerous conditions in maritime usage and have been used throughout history by armies to signal a stop because the enemy is ahead. So if you’ve got a red flag stock, there’s some trouble in your portfolio.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Th
Decades ago, Carl Icahn gained a formative insight from reading the American novelist Theodore Dreiser. The billionaire investor was absorbed by two of Dreiser’s novels, The Financier and The Titan, which chronicle the rise of industrialist Frank Cowperwood. Were it to be deployed, Dreiser writes, “these men should see at last how powerful he was and how secure”.
The Labor Department will release its latest inflation reading and Ford electric vehicle owners will soon be able to use Tesla charging stations. Here’s what investors need to know today.
High hopes for Memorial Day travel, Illumina CEO survives in split decision for Carl Icahn, and other news to start your day.
Plus, the battle heats up between Icahn and Illumina and Cayman Islands defends itself as a go-to for the super-rich
The investment vehicle run by Carl Icahn saw further losses after more light was shone on its potentially unsustainable dividend practices and inflated net asset value (NAV) when famous investor Bill Ackman tweeted about its corporate structure. Shares of Icahn Enterprises are now down 60% year to date. Icahn Enterprises is a publicly traded investment vehicle run by Carl Icahn and his investment team.
YouTube Host Matt Kohrs joins Yahoo Finance Live to discuss the rise of Nvidia stock, what investors should watch for in the AI play for stocks, and the fall of Icahn shares following Ackman's remarks on the Hindenburg Report.
The business empire of corporate raider and activist investor Carl Icahn continues to tumble amid the fallout following a recent report from short-selling firm Hindenburg Research — and losses are accelerating as a longtime rival echoes the firm's allegations. In the report, published on May 2, Hindenburg claimed that Icahn Enterprises has been using inflated asset valuations. Based in Sunny Isles Beach, Florida, Icahn Enterprises has stakes in businesses ranging from food packaging and automotive to real estate and pharmaceuticals.
A few years ago the activist investors clashed over the Herbalife nutrition group. Icahn is currently at the center of a hostile short-seller campaign.
Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc, a partial victory for the activist investor who is struggling to burnish his credentials following a shortseller attack on his company. Illumina said Icahn nominee Andrew Teno won enough shareholder votes for election, confirming an earlier Reuters report. Illumina's market value of $30 billion made the fight this year's largest proxy contest to go to a shareholder vote.
Activist investor Carl Icahn failed to topple the CEO of gene-sequencing giant Illumina in a proxy battle that culminated on Thursday afternoon, but succeeded in getting one of his three nominees onto the company’s board, and knocking out its chairman. The mixed decision represents a rebuke of Illumina (ticker: ILMN) CEO Francis deSouza, though not as severe a punishment as shareholders could have handed him. Icahn sought to replace deSouza as CEO, and one influential proxy advisor recommended that investors vote against his board nomination.
(Bloomberg) -- Illumina Inc. shareholders voted to elect a board member nominated by activist shareholder Carl Icahn, a much-needed partial victory for the billionaire as his investment firm grapples with an attack by short-seller Hindenburg Research. Most Read from BloombergCathie Wood’s ARKK Dumped Nvidia Stock Before $560 Billion SurgeApple Plans to Turn Locked iPhones Into Smart Displays With iOS 17JPMorgan Tells 1,000 First Republic Employees They'll Lose Their JobsFirst Republic’s $35 Mill
Icahn Enterprises LP's stock tumbled as much as 24.7% to $18.03, deepening losses of more than 60% that were recorded following short-seller Hindenburg Research's scathing attack on the company three weeks ago. In a memorable clash a decade ago, the billionaire had shorted supplement company Herbalife, in which activist investor Icahn was a shareholder.
Shares in Icahn Enterprises crashed more than 20% in the wake of [a long tweet](https://twitter.com/BillAckman/status/1661464270255603713) by rival William Ackman, putting the stock on pace for its sharpest decline since short seller Hindenburg Research published a report targeting the company on May 2. Icahn Enterprises, the publicly traded firm controlled by investor Carl Icahn, has lost roughly 60% since Hindenburg alleged that the company was relying on inflated asset valuations and that Mr. Icahn’s borrowing against billions of dollars worth of his shares had left the company dangerously overleveraged.
A long-running feud between activist hedge fund managers Carl Icahn and Bill Ackman is revived as the latter tweets about the embattled shares of the former's investment vehicle.
Icahn Enterprises LP (NASDAQ: IEP), a master limited partnership (MLP), can't seem to find a bottom. IEP's units appear to be reacting negatively to a long-form tweet by billionaire hedge fund manager Bill Ackman Wednesday afternoon. In the tweet, Ackman called the continued tolerance of IEP's margin lenders into question in the wake of Hindenburg Research's May 2 short report, and the MLP's subsequent multibillion-dollar decline in value.
Personal loans secured against the value of Icahn's ownership in his own investment firm could prove highly unstable, the Pershing Square founder warns.
(Bloomberg) -- Bill Ackman said Hindenburg Research has “outed” the way billionaire Carl Icahn runs his publicly traded company and suggested shares have room to fall after tumbling to the lowest levels since 2009.Most Read from BloombergApple Plans to Turn Locked iPhones Into Smart Displays With iOS 17McCarthy Signals Debt Deal Optimism as US Put on Credit WatchUS Credit Rating at Risk of Fitch Cut on Debt-Limit ImpasseWorld’s Biggest Nuclear Plant May Stay Closed Due to Papers Left on Car Roof
The billionaire investor said in a tweet on Wednesday that he was "fascinated" by the situation between the short seller and Icahn Enterprises, while noting that the company's premium had been sustained by a large dividend yield. "The yield is generated by returning capital to outside shareholders, which is in turn funded by the company selling stock to investors," Ackman said, adding the system is highly dependent on the "maintenance of the premium and the placidity of Icahn's margin lender(s)". Bill Ackman declined to comment beyond his tweet.
The practice of short selling is highly controversial and under renewed threat from regulators and politicians who are considering a ban on the practice. Short selling is essentially when traders and investors bet that a stock’s price is going to decline over a certain period of time. These are generally companies that are widely-considered to be stocks to sell, with hedge fund bets against such stocks fueling outsized declines (increasing profits simultaneously). Many people criticize short sel
The legendary activist, whose own company is under attack, has launched a proxy contest for three seats on the gene-sequencing giant’s board, which is mired in a messy acquisition. The stakes are high for both.
A short seller accused the billionaire of covering up his losses by bribing shareholders with a dividend. Now he admits his 'mistake': 'Don't fight the fed'